Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-25 @ 7:50 PM
NCT ID:
NCT00666835
Group ID:
EG001
Title:
ERYPO®, Janssen-Cilag
Description:
Eligible patients were randomized and continued to be treated with ERYPO®, Janssen-Cilag in pre-filled syringes intravenously (solution for injection i.v.) for 24 weeks. The maximum weekly dose was 300 UI/kg body weight (given 1 to 3 times) to maintain hemoglobin levels between 10-13 g/dL. Baseline HB value after 24 weeks was required for efficacy analysis at week 28.
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
57
Serious Number At Risk:
164
Other Number Affected:
154
Other Number At Risk:
164
Study:
NCT00666835
Results Section:
NCT00666835
Adverse Events Module:
NCT00666835